2025
SJR Q2
JCR Q1 · 3,1
OA
4 matched articles
SSCI
Journal detail
Cost Effectiveness and Resource Allocation
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
14787547
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,789
- Quartile Q2
- H-Index 48
- Cites/doc 2,97
- Docs (3y) 253
- Cites (3y) 691
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,1
- 5Y JIF 2,9
- JCI 0,79
WoS indexes
- SSCI
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,789 | 3,1 | 2,9 | 0,79 | Q2 | 48 |
| 2024 | Q2 | Q2 | 0,659 | 2,5 | 2,6 | 0,77 | Q3 | 46 |
| 2023 | Q2 | Q3 | 0,61 | 1,7 | 2,1 | 0,66 | Q3 | 46 |
| 2022 | Q2 | Q3 | 0,53 | 2,3 | 2,4 | 0,7 | Q3 | 46 |
| 2021 | Q2 | Q3 | 0,726 | 2,8 | 3 | 0,82 | Q2 | 46 |
| 2020 | Q2 | Q3 | 0,885 | 2,5 | 2,4 | 0,73 | Q3 | 46 |
| 2019 | Q2 | Q3 | 0,776 | 1,4 | 1,6 | 0,71 | Q3 | 46 |
| 2018 | — | Q3 | — | 1,7 | — | 0,73 | Q2 | — |
| 2017 | Q1 | Q2 | 0,888 | 1,8 | — | 0,76 | Q2 | 46 |
| 2016 | Q1 | Q2 | 1,115 | 1,8 | — | — | — | 46 |
| 2015 | Q1 | — | 0,825 | — | — | — | — | 46 |
| 2014 | Q2 | — | 0,758 | — | — | — | — | 46 |
| 2013 | Q1 | — | 0,841 | — | — | — | — | 46 |
| 2012 | Q1 | — | 0,813 | — | — | — | — | 46 |
| 2011 | Q1 | — | 0,909 | — | — | — | — | 46 |
| 2010 | Q1 | — | 1,02 | — | — | — | — | 46 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | HEALTH POLICY & SERVICES | SSCI | Q1 | Q2 | 31/125 |
| 2024 | HEALTH POLICY & SERVICES | SSCI | Q2 | Q3 | 48/125 |
| 2023 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 76/118 |
| 2022 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 59/87 |
| 2021 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q2 | 45/88 |
| 2020 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 46/88 |
| 2019 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 65/87 |
| 2018 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q2 | 50/82 |
| 2017 | HEALTH POLICY & SERVICES | SSCI | Q2 | Q2 | 38/79 |
| 2016 | HEALTH POLICY & SERVICES | SSCI | Q2 | — | 35/77 |